Entry site of formylmethionyl-tRNA  by Benne, R. & Voorma, H.O.
Volume 20, number 3 FEBS LETTERS February 1972 
ENTRY SITE OF FORMYLMETHIONYL-tRNA 
1. Introduction 
R. BENNE and H.O. VOORMA 
Department of Biochemistry, State University of Leiden, 
64 Wassenaarseweg, Leiden, The Netherlands 
Received 30 November 197 1 
Binding of fMet-tRNA to a ribosome-bacteriophage 
RNA complex, which is mediated by the initiation 
factors F 1, F2 and F3, has been shown to occur either 
with GTP or with GMP-PCP, fi-y-methylene analogue 
of GTP [l-7] . The fMet-tRNA in the 70 S initiation 
complex formed with GTP can react with puromycin, 
whereas Net-tRNA in the complex with GMP-PCP 
cannot [ 1 ] . Because the GTP-analogue is non-hydro- 
lysable, the hypothesis has been put forward that a 
translocation step, which needs GTP-hydrolysis, oc- 
curred during complex formation [S] . These results 
have led to the conclusion that there is one single 
entry site on the ribosome, the A-site, which func- 
tions also for fMet-tRNA [7]. GTP hydrolysis and 
concomitant translocation positions the fMet-tRNA 
into the P-site, where it becomes reactive towards 
puromycin. These observations were also in line with 
further studies, which dealt with binding of a second 
aminoacyl-tRNA to initiation complexes, in which 
either bacteriophage RNA or an AUG2U,, oligonucleo- 
tide was used as mRNA. With bacteriophage MSZRNA 
it was shown that alanyl-tRNA could not enter the ini- 
tiation complex in the presence of GMP-PCP [6], 
whereas valyl-tRNA binding was completely inhibited 
with AUG2U, [4, 51. 
The data we wish to present in this paper, however, 
can best be explained by assuming that fMet-tRNA 
enters directly into the P-site, irrespective whether 
GTP or GMPPCP is used for complex formation 
[8,9]. Our experiments indicate that the puromycin 
reaction with the initiation complex formed with 
GMP-PCP fails because of the blocking of the A-site 
by F2 and GMP-PCP rather than by wrong position- 
ing of the fMet-tRNA itself. 
2. Materials and methods 
Ribosomes were isolated from E. coli, Q 13 strain, 
by alumina grinding as described earlier [6] and 
washed 2 times with 1 M NH4C1. Initiation factor 
F2 and initiation factor complex Fl/F3 were pre- 
pared according to Hershey et al. [ 151 . The fMet- 
tRNA binding assay was performed in 50 mM K- 
acetate, 50 mM Tris-HCl, pH 7.2, 7 mM Mg-acetate, 
50 mM NH4C1 and 1.2 mM /3-mercaptoethanol 
(buffer A); the binding was determined by the Milli- 
pore filter technique. Formylmethionyl-puromycin 
was extracted with ethylacetate at pH 5.5 according 
to Leder and Bursztyn [ 161. Post-column initiation 
complexes were eluted from a 1 .O X 25 cm Sepha- 
dex G-200 column with buffer A. The initiation 
complex containing fractions were pooled and sam- 
ples of 0.1 ml were used for post-column experiments. 
3. Results and discussion 
We believe that meaningful studies about the 
properties of the initiation complex can best be per- 
formed on the isolated complex. The advantage of 
this approach being the absence of all factors which 
were necessary for its formation. In this way we can 
exclude the interference of these factors with sub- 
sequent relevant reactions, e.g. binding of the second 
aminoacyl-tRNA or the puromycin reaction. Thus 
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Table 1 
Puromycin sensitivity of fMet-tRNA in initiation complexes. 
Pre-column 
Preincubation Binding 
(pmoles) 
Puromycin sensitive 
(%) 
+GTP 
+ GMP-PCP 
2.72 86.U 
2.01 18.3 
Post-column 
Preincubation 
+ GTP 
+ GMP-PCP 
Binding 
(pmoles) 
1.80 
2.55 
Puromycin sensitive 
(%) 
80.0 
88.3 
Pre-column: 0.1 ml incubation mixtures in buffer A con- 
tained 120 fig washed ribosomes from E. coli Q13, 10 ccg 
of MSZ-RNA, 0.2 mM GTP or GMPPCP, 20 pmoles of 
f-3H-Met-tRNA (specific activity 7.2 Ci/mM), 1.0 pg of 
F2 and 0.5 fig of Fl/F3-complex and were incubated for 
15 min at 37”. To another set of samples 50 pg of puro- 
mycin was added subsequently and incubated for another 
10 min. Blank values are subtracted. 
Post-column: 0.5 ml incubation mixtures containing 840 pg 
of washed ribosomes, 70 pg of MS2-RNA, 140 pmoles of 
f-3H-Met-tRNA, 7 pg of F2 and 3.5 pg of Fl/F3 were in- 
cubated and passed over Sephadex G-200 as described in 
Materials and methods. 0.1 ml samples of the pooled frac- 
tions were directly filtered over Millipore or incubated for 
another 30 min in the presence of 50 pg of puromycin. 
Binding of fMet-t RNA and fMet-puro formation were de- 
termined as described. The presented figures were cal- 
culated per 0.1 ml of the pre-column incubation mixtures. 
the initiation complex was isolated by gel filtra- 
tion on Sephadex G-200 columns. These isolated 
initiation complexes were tested on their ability to 
perform the formylmethionyl-puromycin reaction. 
The results of this assay are summarized in table 1. 
f?vlet-tRNA bound in the presence of GMP-PCP be- 
comes puromycin sensitive after Sephadex passage, 
whereas it was non-reactive before. This lead us to 
assume that GTP hydrolysis was not necessarily 
needed for positioning the fMet-tRNA in a reactive 
site. A control experiment was set up to check that 
column passage by itself cannot convert a pretrans- 
locational complex into a posttranslocational com- 
plex. This was achieved by binding Phe-tRNA to a 
poly U-ribosome complex in the presence of 
Table 2 
Effect of Sephadex chromatography on A-site 
bound Phe-tRNA. 
Pre-column 
Additions Binding 
(pmoles) 
Puromycin sensitive 
(%) 
_ 
Post-column 
1.05 5.0 
Additions Binding Puromycin sensitive 
(pmoles) (%) 
a. - 1.05 7.9 
b. G 1.05 5.1 
c. GTP 1.05 25.1 
d. GTP+G 1.05 73.2 
Pre-column: 0.1 ml incubation mixtures in buffer A, con- 
taining 120 pg of ribosomes, 10 pg of poly U, 20 pmoles of 
14C-Phe-tRNA (specific activity 514 mCi/mM), 10 ~1 of 
105,000 g supernatant, 0.02 rmoles of GMP-PCP and 50 pg 
of puromycin were incubated at 37”. After 30 min of incu- 
bation a constant binding was reached, indicating that all 
Phe-tRNA bound to the ribosome was puromycin resistent. 
Post-column: 0.5 ml incubation mixtures were incubated 
and passed over Sephadex G-200 as described in Materials 
and methods. 0.1 ml samples of the pooled fractions were 
directly filtered over Millipore or incubated for another 30 min 
in the presence of 50 pg of puromycin, (a); 50 pg of puromy- 
tin and 10 ~1 of 105,000 g supernatant, (b); 50 fig of puro- 
mycin and 0.02 rmoles of GTP, (c); or 50 pg of puromycin, 
0.02 pmoles of GTP and 10 frl of 105,OOOg supernatant, 
(d); whereafter the remaining 14C-Phe-tRNA was counted 
on Millipore. Post-column binding is calculated per 0.1 ml 
pre-column incubation mixture. 
GMP-PCP. Non-enzymic binding in the P-site was re- 
moved by puromycin, whereafter the complex was 
passed through the column. As is shown in table 2 
Phe-tRNA becomes puromycin sensitive only after 
addition of GTP and G factor. The loss of counts in 
the presence of GTP might be due to residual G ac- 
tivity on the ribosome. 
These results lead us to reconsider the initial con- 
cepts of fMet-tRNA binding [l-7] . We postulate there, 
fore that non-reactivity of fMet-tRNA apparently is 
not due to a wrong positioning but more likely to 
the presence of initiation factors or other components 
in initiation complexes which do impair normal ribo- 
somal function. The column procedure presumably 
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Fig. 1. Kinetics of fMet-tRNA binding with varying amounts of F2. Incubation mixtures and ionic conditions identical to those in 
table 1, except that the amount of F2 was varied, 0.1; 0.5 and 1.5 c(g of F2. (o-+-o): 0.2 mM GTP; (o-4): 0.2 mM GMP-PCP. 
Table 3 
Effect of F2, GTP and GMP-PCP on puromycin sensitivity 
of fMet-tRNA. 
Post-column 
Postincubation 
Additions 
Binding 
(pmoles) 
Puromycin sensitive 
(%I 
none 2.55 90.0 
+F2 2.50 92.1 
+GTP 2.50 90.5 
+ GMP-PCP 2.50 89.7 
+F2+GTP 2.55 89.9 
+ F2 + GMP-PCP 2.55 39.1 
+Fl+F2+GTP 2.55 91.2 
+ Fl + F2 + GMP-PCP 2.55 38.7 
Post-column complexes were prepared as described in the 
legend to table 1. Samples of 0.1 ml were submitted to a 
repeated incubation with 1 .O pg of F2,0.5 fig of Fl, 0.02 
pmoles of GTP or GMP-PCP separately or combined as 
shown, all in the presence of 50 fig of puromycin. The puro- 
mycin sensitivity was determined both on Millipore and 
by extraction with ethylacetate. 
removes initiation factors from the complex, thereby 
causing the reactivation of the puromycin reaction. 
For this reason we have incubated post-column com- 
plexes again with either GTP or GMP-PCP and/or F2. 
One observes that only F2 and GMP-PCP in a com- 
bined action can restore the puromycin insensitivity 
of these complexes (table 3). Fl does not play any 
role in this reaction. The results so far presented can 
be contained in the following scheme. During the 
formation of the initiation complex with GTP the 
factors are released. These initiation factors are re- 
cycled in a normal incubation mixture. GMP-PCP, 
however, is thought to prevent or retard this recycling 
of factors. Evidence for such an assumption could be 
obtained from experiments in which F2 was added 
in limiting amounts (see fig. 1). The kinetics of the 
experiments in fig. 1 show that low amounts of F2 
can maintain a reasonable efficient binding of fMet- 
tRNA, however, only in the presence of GTP. With 
GMP-PCP both the initial rate and the saturation 
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Table 4 Table 5 
Effect of F2, GTP and GMP-PCP on 14C-A&RNA binding. Effect of tetracycline on Phe-tRNA and f-Met-tRNA binding. 
Precolumn 
incubation 
Postcolumn 
incubation 
Binding 14C-Ala-tRNA 
(pmoles) 
Assay system Tetracycline 
- F2 + F2 
+GTP +GTP 2.12 2.60 
+GTP + GMP-PCP 1.35 0.76 
+ GMP-PCP +GTP 3.19 3.12 
+ GMPPCP + GMP-PCP 1.91 0.50 
Postcolumn complexes were prepared with f-3H-Met-tRNA 
as described before in the presence of either GTP or GMP- 
PCP. Samples of 0.1 ml were supplied with either 0.02 
pmoles of GTP/GMP-PCP and/or 2.5 pg F2, preincubated 
for 5 min, whereafter 20 pmoles of 14C-Ala-tRNA were 
added and the Mg-concentration raised to 10 mM. Incuba- 
tion was continued for another 15 min. Binding of 14C-Ala- 
tRNA was determined on Millipore filter. Control experi- 
ments without column passage: with GTP, 2.15 pmoles 
14C-Ala-tRNA bound; with GMP-PCP 0.39 pmoles 14C-Ala- 
tRNA bound. 
+ poly u 0 0 0 
+ poly u 1.0 X 1O-4 M 42.5 61.7 
+ poly u 2.0 X lo+ M 61.0 60.3 
+ ApUpG 0 0 0 
+ ApUpG 1.0 X 1O-4 M 0 0 
+ ApUpG 2.0 x 1O-4 M 0 0 
Poly U directed system: see legend to table 2, without tetra- 
cycline the amount of 14C-Phe-tRNA binding was 20.6 and 
6.5 pmoles with GTP and GMP-PCP, respectively. 
AUG-directed system: see legend to table 1, without tetra- 
cycline the amount of f-3H-Met-tRNA binding was 1.75 and 
2.25 pmoles with GTP and GMP-PCP, respectively. 
level of fMet-tRNA binding are at least three times 
lower. On the other hand excess of F2 gives essential- 
ly the same binding level. A likely explanation for 
these results is that F2 is not recycled with GMP-PCP, 
acts stoichiometrically, and that GTP hydrolysis 
might be the driving force for recycling. 
So far our hypothesis is based mainly on puro- 
mycin reactions, If one assumes that inhibition of 
the fMet-puromycin reaction is generated by block- 
ing or altering the A-site characteristics by the pres- 
ence of F2 on the ribosome, one can predict that 
also the binding of alanyl-tRNA, which is the second 
aminoacyl-tRNA to be bound in a MS2-RNA-ribo- 
some complex, must be impaired by F2 and GMP- 
PCP. The data on experiments of this kind are pre- 
sented in table 4 and are consistent with this hypo- 
thesis. 
It was already known that in normal incubation 
mixtures GMP-PCP could inhibit Ala-tRNA binding 
[6]. However, after passage through Sephadex G-200 
both complexes, preincubated with either GTP or 
GMP-PCP, are able to bind Ala-tRNA. Again addi- 
tion of GMPPCP and F2 causes a strong inhibition 
of this binding reaction. These findings readily suggest 
that also in these experiments attachment of F2 and 
probably of GMP-PCP to the initiation complex re- 
stricts the ability of the ribosome to perform its 
normal function, i.e. the presence of F2 in the 
initiation complex blocks or alters the A-site. From 
these data we have obtained evidence that the A-site 
is not involved in the binding of fMet-tRNA. This is 
supported by experiments in which tetracycline is 
used [7,9]. Under conditions where Phe-tRNA 
binding is significantly inhibited by tetracycline we 
could not detect any inhibition of fMet-tRNA bind- 
ing (table 5). Since tetracycline only interferes with 
binding in the A-site, we like to conclude that fMet- 
tRNA directly enters the P-site, as was originally 
proposed by Bretscher, Clark and Marcker [8,9]. 
Evidence obtained by other experimental procedures 
does support this final conclusion [lo- 131. The 
suggested altered P-site, the so-called P-aligned site 
[ 141 and the pre-P-site [ II] might well correspond 
to initiation complexes from which the initiation 
factor has not yet been removed. 
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